Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | June 2009

Providing Evidence for Plaque Excision

Coprincipal investigators James F. McKinsey, MD, and Lawrence A. Garcia, MD, discuss their new clinical trial to study plaque excision in PAD patients.

By James F. McKinsey, MD, and Lawrence A. Garcia, MD

evt | Article | November 2008

Long-Term Evaluation of Percutaneous Directional Atherectomy

An interview with James F. McKinsey, MD, about the use of percutaneous directional atherectomy in 579 lesions in the treatment of lower extremity ischemia.

evt | Article | August 2005

A Safe and Effective Primary Treatment Option

By Lawrence A. Garcia, MD, and James F. McKinsey, MD

evt | Article | August 2011

A Multidisciplinary Approach to CLI Management

Why your hospital should support the development of a dedicated limb salvage team.

By James F. McKinsey, MD, FACS; Thomas P. Davis, MD; and Gautam V. Shrikhande, MD

Advertisement

Advertisement

evt | Article | September 2005

Plaque Excision in 2005 and Beyond: Rebuttal

Rebuttal of “Issues of the Past Have Yet to Be Resolved”

By Lawrence A. Garcia, MD, and James F. McKinsey, MD

evt | Article | April 2007

In-Stent Restenosis of the SFA

Two case studies using a retrograde approach with a combination of different devices to treat recurrent lower-extremity ischemia.

By Soo Rhee, MD, and James F. McKinsey, MD

evt | Article | November 2012

From Data to Decision: How Will We Apply the 12-Month DEFINITIVE LE Evidence to Clinical Practice?

An interview with Lawrence A. Garcia, MD, and James F. McKinsey, MD

evt | Article | November 2016

Expanding the Landing Zone for TEVAR

A discussion of the longevity and durability of commonly used extrathoracic debranching techniques.

By Daniel K. Han, MD, RPVI; Christine Jokisch, BS; and James F. McKinsey, MD

evt | Article | November 2007

TEVAR for the Ruptured Thoracic Aorta

As operator experience increases and our approaches to treating branch vessels progress, the limitations associated with TEVAR will decrease.

By Lee J. Goldstein, MD; Venkatesh G. Ramaiah, MD; and James F. McKinsey, MD

evt | Article | November 2017

Ask the Experts: What Is Your Protocol for Following Patients After TEVAR?

Expects comment on their approach to surveillance for patients with aneurysmal disease versus aortic dissection.

With Rajesh K. Malik, MD, FACS, RPVI; Tilo Kölbel, MD, PhD; Patrick Kelly, MD; and James F. McKinsey, MD

evt | News | August 17, 2014

DEFINITIVE LE Supports Directional Atherectomy With Covidien's TurboHawk and SilverHawk

August 18, 2014—Covidien announced the publication of the DEFINITIVE LE study results demonstrating that directional atherectomy using the company’s TurboHawk and/or SilverHawk system is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD).

evt | News | October 27, 2015

Subset Analysis of DEFINITIVE LE Supports Directional Atherectomy in Diabetic Patients

October 27, 2015—In the International Society of Endovascular Specialists’ Journal of Endovascular Therapy (JEVT), Lawrence A. Garcia, MD, et al published findings from a comparison of clinical outcomes for diabetic and nondiabetic patients after directional atherectomy in the DEFINITIVE LE claudicant cohort (2015;22:701–711). This subset analysis evaluated the hypothesis that directional atherectomy for peripheral artery disease in diabetic claudicants has noninferior primary patency at 12 months compared with nondiabetic claudicants.

evt | Article | August 2011

Progress in Amputation Prevention

By Jihad A. Mustapha, MD, FACC, FSCAI, Guest Chief Medical Editor

evt | Article | April 2008

Thoracic Endograft Performance Evaluations

Insights shared at the 2007 Cleveland Clinic Stent Summit.

By Robert G. Whirley, PhD; Mike Nilson, BS; Catherine Szyman, MBA; Matthew S. Waninger, PhD; and Roy K. Greenberg, MD

evt | News | December 2, 2015

DEFINITIVE LE Subgroup Data Support Directional Atherectomy of Infrapopliteal Artery Lesions

December 3, 2015—One-year effectiveness outcomes from a subgroup of patients who underwent directional atherectomy of infrapopliteal artery lesions in the DEFINITIVE LE trial were published by Aljoscha Rastan, MD, et al in the Journal of Endovascular Therapy (JEVT, 2015;22:839-846).

evt | Article | November 2016

Practical Thoracic Decision Making

By Edward Y. Woo, MD, and Ian M. Loftus, MD, FRCS

evt | Article | November 2007

All Eyes on TEVAR

By Takao Ohki, MD, PhD

evt | Article | April 2007

Meeting the Challenge

By Barry T. Katzen, MD, Chief Medical Editor

evt | News | January 26, 2014

FDA Clears AtheroMed's Phoenix Atherectomy System to Treat Peripheral Artery Disease

January 27, 2014—AtheroMed, Inc. (Menlo Park, CA) announced that it has received US Food and Drug Administration (FDA) clearance to market the Phoenix atherectomy system for the treatment of peripheral artery disease.

evt | Article | November 2012

Chief Medical Editor's Page

VTE Therapy

By Barry T. Katzen, MD


1

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button